» Authors » T C El-Galaly

T C El-Galaly

Explore the profile of T C El-Galaly including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 126
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jemaa S, Paulson J, Hutchings M, Kostakoglu L, Trotman J, Tracy S, et al.
Cancer Imaging . 2022 Aug; 22(1):39. PMID: 35962459
Background: Current radiological assessments of fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging data in diffuse large B-cell lymphoma (DLBCL) can be time consuming, do not yield real-time information regarding disease burden and...
2.
El-Galaly T, Villa D, Gormsen L, Baech J, Lo A, Cheah C
J Intern Med . 2018 Jul; 284(4):358-376. PMID: 29989234
FDG-PET/CT is the current state-of-the-art imaging in lymphoma and plays a central role in treatment decisions. At diagnosis, accurate staging is crucial for appropriate therapy selection: FDG-PET/CT can identify areas...
3.
Wasterlid T, Biccler J, Brown P, Bogsted M, Enblad G, Meszaros Jorgensen J, et al.
Ann Oncol . 2018 May; 29(8):1882-1883. PMID: 29790897
No abstract available.
4.
Chin C, Tsang E, Mediwake H, Khair W, Biccler J, Hapgood G, et al.
Br J Haematol . 2018 Apr; 184(5):826-828. PMID: 29676487
No abstract available.
5.
Alzahrani M, El-Galaly T, Hutchings M, Hansen J, Loft A, Johnsen H, et al.
Ann Oncol . 2016 Mar; 27(6):1095-1099. PMID: 27002106
Background: The added diagnostic and prognostic value of routine bone marrow biopsy (BMB) in patients with diffuse large B-cell lymphoma (DLBCL) undergoing positron emission tomography combined with computed tomography (PET/CT)...
6.
Schjelderup P, El-Galaly T, Frokjaer J, Ring T
Z Rheumatol . 2014 May; 73(10):939-41. PMID: 24830677
We present a report of what we believe was an extremely rare case of hyperacute respiratory failure caused by first time exposure to cyclophosphamide in a 40-year-old woman with systemic...
7.
El-Galaly T, Mylam K, Bogsted M, Brown P, Rossing M, Gang A, et al.
Am J Hematol . 2014 Feb; 89(6):575-80. PMID: 24493389
After first-line therapy, patients with Hodgkin lymphoma (HL) and aggressive non-HL are followed up closely for early signs of relapse. The current follow-up practice with frequent use of surveillance imaging...
8.
El-Galaly T, Kristensen S, Overvad K, Steffensen R, Tjonneland A, Severinsen M
J Thromb Haemost . 2012 May; 10(10):2191-3. PMID: 22577971
No abstract available.